These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 22336645)

  • 1. The pathophysiology of endothelial function in pregnancy and the usefulness of endothelial markers.
    Slavik L; Prochazkova J; Prochazka M; Simetka O; Hlusi A; Ulehlova J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2011 Dec; 155(4):333-7. PubMed ID: 22336645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial cell activation in cutaneous vasculitis.
    Jurd KM; Stephens CJ; Black MM; Hunt BJ
    Clin Exp Dermatol; 1996 Jan; 21(1):28-32. PubMed ID: 8689765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of matrix metalloproteinases, (MMPs) their tissue inhibitors, and vascular endothelial growth factor (VEGF) in growth plates of children and adolescents indicates a role for MMPs in human postnatal growth and skeletal maturation.
    Haeusler G; Walter I; Helmreich M; Egerbacher M
    Calcif Tissue Int; 2005 May; 76(5):326-35. PubMed ID: 15868281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased TIMP/MMP ratio in varicose veins: a possible explanation for extracellular matrix accumulation.
    Badier-Commander C; Verbeuren T; Lebard C; Michel JB; Jacob MP
    J Pathol; 2000 Sep; 192(1):105-12. PubMed ID: 10951407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome.
    Gonçalves FM; Jacob-Ferreira AL; Gomes VA; Casella-Filho A; Chagas AC; Marcaccini AM; Gerlach RF; Tanus-Santos JE
    Clin Chim Acta; 2009 May; 403(1-2):173-7. PubMed ID: 19254704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of vascular matrix metalloproteinase inducer and activator proteins in hypertensive patients.
    Ergul A; Portik-Dobos V; Hutchinson J; Franco J; Anstadt MP
    Am J Hypertens; 2004 Sep; 17(9):775-82. PubMed ID: 15363819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased levels of atherosclerosis markers in salt-sensitive hypertension.
    Larrousse M; Bragulat E; Segarra M; Sierra C; Coca A; de La Sierra A
    Am J Hypertens; 2006 Jan; 19(1):87-93. PubMed ID: 16461197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic in vivo changes in the activities of gelatinases, matrix metalloproteinases (MMPs), and tissue inhibitor of metalloproteinases (TIMPs) in buffalo (Bubalus bubalis) uterine luminal fluid during estrous cycle and early pregnancy.
    Roy SC; Ghosh J
    Mol Reprod Dev; 2010 Nov; 77(11):944-53. PubMed ID: 20886603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct modes of collagen type I proteolysis by matrix metalloproteinase (MMP) 2 and membrane type I MMP during the migration of a tip endothelial cell: insights from a computational model.
    Karagiannis ED; Popel AS
    J Theor Biol; 2006 Jan; 238(1):124-45. PubMed ID: 16005020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and activation of MMP -2, -3, -9, -14 are induced in rat colon after abdominal X-irradiation.
    Strup-Perrot C; Vozenin-Brotons MC; Vandamme M; Benderitter M; Mathe D
    Scand J Gastroenterol; 2006 Jan; 41(1):60-70. PubMed ID: 16373278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Monitoring of endothelial activation markers during physiological pregnancy].
    Procházková J; Dhaifallah I; Mechurová A; Pilka R; Simetka O; Slavík L; Ulehlová J; Lubuský M; Procházka M
    Ceska Gynekol; 2010 Apr; 75(2):92-100. PubMed ID: 20518260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases-1 and -2 levels in gestational hypertension.
    Tayebjee MH; Karalis I; Nadar SK; Beevers DG; MacFadyen RJ; Lip GY
    Am J Hypertens; 2005 Mar; 18(3):325-9. PubMed ID: 15797648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased concentration of tissue-degrading matrix metalloproteinases and their inhibitor in complicated diverticular disease.
    Rosemar A; Ivarsson ML; Börjesson L; Holmdahl L
    Scand J Gastroenterol; 2007 Feb; 42(2):215-20. PubMed ID: 17327941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular matrix remodelling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitors.
    Fondard O; Detaint D; Iung B; Choqueux C; Adle-Biassette H; Jarraya M; Hvass U; Couetil JP; Henin D; Michel JB; Vahanian A; Jacob MP
    Eur Heart J; 2005 Jul; 26(13):1333-41. PubMed ID: 15827062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of metalloproteases and inhibitors in the occurrence and progression of diabetic renal lesions.
    Zaoui P; Cantin JF; Alimardani-Bessette M; Monier F; Halimi S; Morel F; Cordonnier D
    Diabetes Metab; 2000 Jul; 26 Suppl 4():25-9. PubMed ID: 10922970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Balance between matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMP) in the cervical mucus plug estimated by determination of free non-complexed TIMP.
    Becher N; Hein M; Uldbjerg N; Danielsen CC
    Reprod Biol Endocrinol; 2008 Sep; 6():45. PubMed ID: 18826601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinase expression by endothelial cells in collagen lattices changes during co-culture with fibroblasts and upon induction of decorin expression.
    Schönherr E; Schaefer L; O'Connell BC; Kresse H
    J Cell Physiol; 2001 Apr; 187(1):37-47. PubMed ID: 11241347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenic and prothrombotic markers in extensive slow-flow vascular malformations: implications for antiangiogenic/antithrombotic strategies.
    Redondo P; Aguado L; Marquina M; Paramo JA; Sierra A; Sánchez-Ibarrola A; Martínez-Cuesta A; Cabrera J
    Br J Dermatol; 2010 Feb; 162(2):350-6. PubMed ID: 19769632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative assessment of matrix metalloproteinase (MMP)-2 and MMP-9, and their inhibitors, tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in preeclampsia and gestational hypertension.
    Palei AC; Sandrim VC; Cavalli RC; Tanus-Santos JE
    Clin Biochem; 2008 Jul; 41(10-11):875-80. PubMed ID: 18477480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of IL-1alpha on the expression of matrix metalloproteinases, plasminogen activators, and their inhibitors in osteoblastic ROS 17/2.8 cells.
    Fujisaki K; Tanabe N; Suzuki N; Mitsui N; Oka H; Ito K; Maeno M
    Life Sci; 2006 Mar; 78(17):1975-82. PubMed ID: 16313928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.